Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intra-articular Injection of UC-MSC Exosome in Knee Osteoarthritis
Sponsor: Universidad de los Andes, Chile
Summary
The study aim to evaluate safety of exosomes (sEVs) from allogeneic mesenchymal stromal cells delivered by an intra-articular injection in the knee of patients with mild to moderate symptomatic osteoarthritis. The sEVs will be produced in a GMP-facility. The investigators expect to enroll 12 patients in this phase 1 trial open label dose-escalation pilot and the follow-up will be up to 12 months.
Official title: Administration of sEV Derived From UC-MSC in Patients With Osteoarthritis of the Knee: Safety Determination in a Pilot Dose-escalation Study
Key Details
Gender
All
Age Range
30 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2024-06-01
Completion Date
2025-12-31
Last Updated
2024-05-29
Healthy Volunteers
No
Conditions
Interventions
UC-MSC sEV
Small extracellular vesicles derived from allogenic mesenchymal stromal cells, single dose
Locations (1)
Clinica Universidad de los Andes
Santiago, Las Condes, Chile